Failure of high-dose oral acyclovir with or without immune globulin to prevent primary cytomegalovirus disease in recipients of solid organ transplants

[1]  E. Spitznagel,et al.  Symptomatic cytomegalovirus infection in renal transplant recipients given either Minnesota antilymphoblast globulin (MALG) or OKT3 for rejection prophylaxis. , 1993, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[2]  D. Dunn,et al.  Sequential therapy--a prospective randomized trial of MALG versus OKT3 for prophylactic immunosuppression in cadaver renal allograft recipients. , 1992, Transplantation.

[3]  T. Merigan,et al.  A controlled trial of ganciclovir to prevent cytomegalovirus disease after heart transplantation. , 1992, The New England journal of medicine.

[4]  J. Cooper,et al.  Failure of prophylactic ganciclovir to prevent cytomegalovirus disease in recipients of lung transplants. , 1992, The Journal of infectious diseases.

[5]  R. Schooley,et al.  SYMPTOMATIC CYTOMEGALOVIRUS DISEASE IN THE CYTOMEGALOVIRUS ANTIBODY SEROPOSITIVE RENAL TRANSPLANT RECIPIENT TREATED WITH OKT31,2 , 1992, Transplantation.

[6]  G. Robertson,et al.  Disorders of water balance--hyponatraemia and hypernatraemia. , 1992, Bailliere's clinical endocrinology and metabolism.

[7]  J. Meyers,et al.  Early treatment with ganciclovir to prevent cytomegalovirus disease after allogeneic bone marrow transplantation. , 1991, The New England journal of medicine.

[8]  O. Toupance,et al.  Acyclovir to prevent cytomegalovirus infection after renal transplantation. , 1991, Annals of internal medicine.

[9]  J. Niland,et al.  A Randomized, Controlled Trial of Prophylactic Ganciclovir for Cytomegalovirus Pulmonary Infection in Recipients of Allogeneic Bone Marrow Transplants , 1991 .

[10]  H. Balfour.  Options for prevention of cytomegalovirus disease. , 1991, Annals of internal medicine.

[11]  D. Snydman,et al.  Final analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus-immune globulin: comparison of the randomized and open-label trials. , 1991, Transplantation proceedings.

[12]  K. Moder,et al.  Fatal hypernatremia from exogenous salt intake: report of a case and review of the literature. , 1990, Mayo Clinic proceedings.

[13]  C. Davis,et al.  The prevention of cytomegalovirus disease in renal transplantation. , 1990, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[14]  R. Rubin.  Impact of cytomegalovirus infection on organ transplant recipients. , 1990, Reviews of infectious diseases.

[15]  H. Balfour,et al.  A randomized, placebo-controlled trial of oral acyclovir for the prevention of cytomegalovirus disease in recipients of renal allografts. , 1989, The New England journal of medicine.

[16]  D. Snydman,et al.  A further analysis of primary cytomegalovirus disease prevention in renal transplant recipients with a cytomegalovirus immune globulin: interim comparison of a randomized and an open-label trial. , 1988, Transplantation proceedings.

[17]  D. Stover,et al.  Cytomegalovirus pneumonia after bone marrow transplantation successfully treated with the combination of ganciclovir and high-dose intravenous immune globulin. , 1988, Annals of internal medicine.

[18]  L. Finberg,et al.  Safe management of diabetic ketoacidemia. , 1988, The Journal of pediatrics.

[19]  D. Abendroth,et al.  Four-year experience with exclusive use of cytomegalovirus antibody (CMV-Ab)-negative donors for CMV-Ab-negative kidney recipients. , 1988 .

[20]  M. Thornquist,et al.  Acyclovir for prevention of cytomegalovirus infection and disease after allogeneic marrow transplantation. , 1988, The New England journal of medicine.

[21]  A. Levey,et al.  Use of cytomegalovirus immune globulin to prevent cytomegalovirus disease in renal-transplant recipients. , 1987, The New England journal of medicine.

[22]  R. Gale,et al.  Intravenous immune globulin for prevention of cytomegalovirus infection and interstitial pneumonia after bone marrow transplantation. , 1987, Annals of internal medicine.

[23]  J. Balfe,et al.  Severe salt poisoning in an infant. , 1976, The Journal of pediatrics.

[24]  Willard A. Burns,et al.  Report of a Case and Review of the Literature , 2017 .

[25]  L. Finberg.  Hypernatremic (hypertonic) dehydration in infants. , 1973, The New England journal of medicine.

[26]  R. Hill,et al.  Fatal poisoning from salt used as an emetic. , 1973, American journal of diseases of children.

[27]  L. Finberg.  Hypernatremic dehydration. , 1969, Advances in pediatrics.

[28]  L. Finberg,et al.  Mass accidental salt poisoning in infancy. A study of a hospital disaster. , 1963, JAMA.

[29]  L. Finberg,et al.  Peritoneal dialysis for salt poisoning. Report of a case. , 1960, New England Journal of Medicine.